Case report: Adenosquamous carcinoma of the prostate with greater than 20 month response to multimodal therapy

Urol Case Rep. 2019 Dec 3:29:101084. doi: 10.1016/j.eucr.2019.101084. eCollection 2020 Mar.

Abstract

Adenosquamous carcinoma is an extremely rare and lethal subtype of prostate cancer affecting an estimated 0.03 per million men annually. It has been associated with prior hormone therapy for prostate adenocarcinoma. We present a case of de novo adenosquamous carcinoma of the prostate treated with a multimodal approach including surgery, androgen-deprivation therapy, chemotherapy, and radiation.

Keywords: Adenosquamous; Carcinoma; Neoplasms; Prostate.

Publication types

  • Case Reports